Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy is a research paper published in Journal for ImmunoTherapy of Cancer (2022). On theSindex it has a DataRank of 0.685. It has been cited 95 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.685
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Melanoma Research Alliance
Grant: N/A
NIH
Grant: AG067441
NIH
Grant: CA184379
NIH
Grant: CA237149
NIH
Grant: CA242188
National Institutes of Health
Grant: 1R01CA184379-01A1
Gamma/Delta Treg Cells and Human Breast Cancer
National Institutes of Health
Grant: 5R01CA242188-02
Targeting T Cell Senescence and Dysfunction for Anti-tumor Immunity
National Institutes of Health
Grant: 7R21AG067441-02
Role of Senescent T cells in Alzheimer's Disease
National Institutes of Health
Grant: 1R01CA237149-01A1
Metabolic Control of Innate and Adaptive Immunity in Breast Cancer
NCI NIH HHS
Grant: R01 CA242188
NCI NIH HHS
Grant: R01 CA184379
NIA NIH HHS
Grant: R21 AG067441
NIA NIH HHS
Grant: R01 AG078822
NCI NIH HHS
Grant: R01 CA237149
FWCI
7.92
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals